摘要
目的观察评价尿激酶静脉溶栓治疗心肌梗死的疗效及安全性。方法35例符合溶栓适应证的急性心肌梗死患者,在常规治疗的同时给予尿激酶100-150万U静脉滴注,观察患者2h内胸痛缓解情况,2h内每30min描记ECG1次,24h内每2h查CK及CK—MB1次。结果35例符合冠脉再通者26例,再通率74.29%;其中5例发生皮肤粘膜、齿龈出血及穿刺部位出血,死亡2例,为冠脉未通者。结论尿激酶静脉溶栓疗效可靠、安全、使用方便、副作用发生率低且轻微,适合基层医院对AMI的抢救。
Objective Observe the safety and effect of using Urokinase Intraenous Thrombolysis to treat Acute Myocardial Infarction. Methods 35 Patients of Acute Myocardial Infarction are under regular treatment and at the same time give intravenous drip of 100 - 150m u Urokinase. Observe the patients relieving condition of thoraealgia in 2hours, one ECG every 30 minutes in 2 hours and check CK/CK - MB1 every 2 hour in 24hrs. Results 26 cases of the 35 patients are in accordance with revascularization and its rate reach 74.29%. 5 cases with skin mucous tunic, gingival bleeding happened and puncture point bleeding, 2 cases dead for failure of coronary circulation. Conclusion Using Urokinase to carry out Intravenous Thrombolytic is simple, safe and low side - effect, it' s adequate for basic level hospital to carry out AMI rescue.
出处
《现代医院》
2009年第12期27-28,共2页
Modern Hospitals
关键词
心肌梗死
静脉溶栓
尿激酶
Acute Myocardial Infarction, Intravenous Thrombolytic, Urokinase